This site uses cookies to ensure the best viewing experience for our readers. Read more about it Got it

Tower Semiconductor Announces Medical Chip Development With Chinese Biotech Company Axbio

Tower stated the device, which is intended for blood test analyses, is planned to go into production in mid-2019

Hezi Sternlicht 16:0206.03.19
Israel-based and Nasdaq-listed wireless chip and camera sensors manufacturer Tower Semiconductor Ltd. has announced on Tuesday the release of a special chip for the medical industry. The chip was developed in Tower Semiconductor’s Japan-based 300mm manufacturing facility in collaboration with Shenzen-based Axbio Inc.

 

The chip, developed based on Tower's 65nm RFCMOS platform, is a microfluidics Bio/CMOS device for molecular in vitro diagnostics. Tower said the device, which is intended for blood test analyses, is planned to go into production in mid-2019.

 

A slowdown in the mobile chip market cut Tower's profit over the past year, leading the company to branch into other, less impacted domains. The company gained 10% on Nasdaq since publishing in February fourth quarter and full year earnings report for the fiscal year 2018, which though less than stellar still exceeded analyst expectations.

 

Nasdaq. Photo: Shutterstock: Nasdaq. Photo: Shutterstock:

 

Cancel Send
    To all comments